Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Daily Wolverine.
Press releases published on April 2, 2025
'THE SOBER WITCH LIFE' BECOMES FIRST RECOVERY BOOK FOR WITCHES
EIN Presswire
·
April 2, 2025
New book blends addiction recovery with witchcraft, ritual, and personal transformation. DETROIT, MI, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- A historic offering has emerged at the intersection of spirituality, witchcraft, and recovery. The …
Improving Medication Adherence in Detroit: A Pharmacist's Perspective
EIN Presswire
·
April 2, 2025
Pharmacists now have access to a revolutionary tool called Meticap, designed to support patients in taking their medications consistently and accurately. DETROIT, MI, UNITED STATES, April 2, 2025 /EINPresswire.com/ -- Adherence to prescribed medication …
CTR Investments & Consulting Inc. Completes Acquisition of Shibue Couture, Inc.
GlobeNewswire
·
April 2, 2025
PALM DESERT, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- CTR Investments …
CMTS Expands in 2025 to Meet Ever-Evolving Needs of Manufacturing Industry
GlobeNewswire
·
April 2, 2025
TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- SME, the nonprofit committed to accelerating adoption of advanced manufacturing technologies and building North America’s talent and capabilities, will expand its Canadian Manufacturing Technology Show (CMTS) in …
Utilities Win Back Favor as Customers Find It Easier to Do Business With Them
GlobeNewswire
·
April 2, 2025
LIVONIA, Mich., April 02, 2025 (GLOBE NEWSWIRE) -- A new Cogent Syndicated report from Escalent reveals that utilities are finally gaining ground in the struggle to make it easy for their customers to do business with them. For the first time since 2021, …
Opus Genetics to Participate in Upcoming Investor Conference in April
GlobeNewswire
·
April 2, 2025
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other …